Sentences with phrase «number of programs for»

A number of programs for school - based teaching of social and emotional skills have been developed in Australia and internationally.

The Society offers a compelling presentation schedule that is promising excellent programming for all attendee's along with a number of programs for continuing education (CE) credits.

In addition to all of the educational loan forgiveness and cancellation programs that are available for teachers, there are also a number of programs for graduates in other professions.

He has anchored a number of programs for the network through the years, including «Market Wrap,» «Mutual Fund Investor,» «The Money Club» and the very popular «Power Lunch,» which he had co-hosted with Sue Herera.

Previous to this, she was selected by Teach for America to join the NYC Corps of 2002, where she taught 6th grade for two years, initiated a number of programs for at - risk youth, served as the TFA School Leader at Community Intermediate School 232, and was the Sue Lehman regional finalist in the NYC corps.

Over the next ten years, she worked on a number of programs for KDE, culminating with the Kentucky Instructional Discipline and Support (K.I.D.S) project, a statewide initiative to help schools and districts develop positive, proactive, and instructional discipline policies.

Sports Camps Canada offers a number of programs for a variety of age groups.

Although iTunes U originally started as a tool for college - aged students, there are now a number of programs for younger students.

That summer, after two more hospitalizations, Jake's desperate parents sent him to Mountain Valley in New Hampshire, a residential treatment facility and one of a growing number of programs for acutely anxious teenagers.

Griffeth has anchored a number of programs for the network through the years, most recently, Closing Bell.

Lang hosted a number of programs for ROBTv with scintillating titles like The Commodities Report.

He has anchored a number of programs for the network through the years, including «Market Wrap,» «Mutual Fund Investor,» «The Money Club» and the very popular «Power Lunch, «which he had co-hosted with Sue Herera.

Not exact matches

For 15 years in a row, the number of applicants for H - 1B work visas has far exceeded the program's cap of 85,000 available visFor 15 years in a row, the number of applicants for H - 1B work visas has far exceeded the program's cap of 85,000 available visfor H - 1B work visas has far exceeded the program's cap of 85,000 available visas.

A number of prominent state universities have launched programs to prepare students for the legal cannabis industry.

By having a limited number of accelerators, investors were able to better vet the startups accepted into the program, which allowed for a greater chance for companies to receive capital.

NYU recently launched its 10 - week accelerator program Launchpad for a select number of startup teams within the university's student pool.

«What he knows is that the old program covered 20 percent to 30 percent of phone numbers to search for terrorists, Cruz said, by way of explaining his vote.

Topics included: early reporting on inaccuracies in the articles of The New York Times's Judith Miller that built support for the invasion of Iraq; the media campaign to destroy UN chief Kofi Annan and undermine confidence in multilateral solutions; revelations by George Bush's biographer that as far back as 1999 then - presidential candidate Bush already spoke of wanting to invade Iraq; the real reason Bush was grounded during his National Guard days — as recounted by the widow of the pilot who replaced him; an article published throughout the world that highlighted the West's lack of resolve to seriously pursue the genocidal fugitive Bosnian Serb leader Radovan Karadzic, responsible for the largest number of European civilian deaths since World War II; several investigations of allegations by former members concerning the practices of Scientology; corruption in the leadership of the nation's largest police union; a well - connected humanitarian relief organization operating as a cover for unauthorized US covert intervention abroad; detailed evidence that a powerful congressional critic of Bill Clinton and Al Gore for financial irregularities and personal improprieties had his own track record of far more serious transgressions; a look at the practices and values of top Democratic operative and the clients they represent when out of power in Washington; the murky international interests that fueled both George W. Bush's and Hillary Clinton's presidential campaigns; the efficacy of various proposed solutions to the failed war on drugs; the poor - quality televised news program for teens (with lots of advertising) that has quietly seeped into many of America's public schools; an early exploration of deceptive practices by the credit card industry; a study of ecosystem destruction in Irian Jaya, one of the world's last substantial rain forests.

To shape and vet the curriculum, the school has signed up a number of industry partners, including Telus, Hootsuite and Live Nation — ideally, these companies will also consider Red Academy grads for available positions, though the program doesn't guarantee employment.

Ottawa could find savings of $ 730 million today if it made the above changes and that number would grow over time as more Canadians become eligible for retirement programs, the report said.

ICANN (the International Corporation for Assigned Names and Numbers), the body that's responsible for domain name and IP address assignment, shook the industry up even more in June with the announcement of the new gTLD program, which would allow established «entities» to apply for new gTLDs outside of the current 21 offered — presenting the possibility that sure - to - be-popular extensions like.

With more MBA programs than ever before serving a record number of students — about 10,000 students are registered in Canadian MBA programs this year, up from 4,800 in 1998 — specialization has become a defining trend, helping schools compete for the best students, and graduates compete for the best jobs.

On the agenda for discussion: whether the FDA should implement a mandatory education program on opioid prescription for doctors, and whether the agency should limit the number of opioid doses a patient is prescribed.

The company took advantage of a number of U.S. programs meant to spur «orphan drugs,» or treatments for the kinds of disorders that afflict less than 200,000 Americans each year.

Over the past few years a growing number of entrepreneurs have forged a quiet revolution in compensation plans, jettisoning traditional salary structures and carving out bold new incentive programs for their entire organizations.

She also drew up a step - by - step sequence of operations for programming Babbage's engine to generate a complex series known as Bernoulli numbers.

For starters, it's football season, which means that we have a number of on - going promotions at our restaurant including a limited - time menu featuring game - day grub, a digital loyalty program and Super Bowl ticket giveaway, among a number of other NFL season festivities and celebrations.

Seeking to provide classes for kids eighteen months and up, she founded Little Kickers, a program that promotes a curriculum of early learning skills (colours, numbers, etc.) alongside a love of sport.

While a number of programs are now being linked to credit cards, there are still incentives for you if you don't have a specific card.

I've observed for some time how CEOs and other executives can't keep their cybersecurity programs in a silo where only a certain number of people fully understand and appreciate their impact.

Earlier this month, it was revealed the number of applications for H - 1B visas — a similar, coveted program for companies to onboard specialized foreign labor — declined for the second year in a row, as the administration moves to streamline the program.

That's now the case for hundreds of students at the University of South China, which according to a number of news outlets has essentially barred those who are in their second year of the school's civil - engineering program from selecting their specialties; the program is broken down into seven of them.

The percentage of women coached by women has declined to an all - time low, even while Title IX, which prohibits sex - based discrimination in any education program or activity that receives federal dollars, has dramatically increased participation numbers for female athletes.

The incentives have spurred a number of state - level experiments in Medicaid (America's health - insurance program for the poor) through waivers of the standard rules.

If New York City — whose Citi Bike program is the largest bike share in the United States — were to match that ratio, it would need to multiply the number of blue for - hire bicycles by 50.

Starkman also says that if employees want to be rewarded for participating in their employer's wellness program, it should be their personal decision whether to directly provide data such as calorie intake and number of steps taken to their employer.

Vice has said it wants to expand into offering more traditional types of programming in more than 80 countries this year, and has signed a number of deals with media companies and telecom providers in the Middle East and Asia for distribution.

But a pretty hefty number of Americans seem to signed up this year for a program that's ostensibly dead and rotting — about 11.8 million, in fact, according to final government numbers released by the Centers for Medicare & Medicaid Services (CMS) on Tuesday.

The findings are skewed by the high numbers of students who enroll in for - profit schools and end up dropping out before they finish their programs.

For example, Pfizer said in January that it will be cutting 300 jobs as part of its closing of its neuroscience research and development program, and it was a brutal 2017 for Alzheimer's research as a number of key trials failFor example, Pfizer said in January that it will be cutting 300 jobs as part of its closing of its neuroscience research and development program, and it was a brutal 2017 for Alzheimer's research as a number of key trials failfor Alzheimer's research as a number of key trials failed.

The earliest programs in central Canada air at 6 a.m. and Atlantic Canada at 7 a.m. Numbers from the Television Bureau of Canada show that consistently for the past six years, the 4 a.m. to 5 a.m. slot has had the fewest viewers, with an audience size about one - fifth of the peak time between 9 p.m. to 10 p.m. Still, Canadian broadcasters aren't overlooking the value of starting early.

A number of companies, including Audi, Bosch, Daimler's Mercedes - Benz unit, Delphi Automotive (DLPH), Google, and Nissan have permits through a California DMV program for testing self - driving cars.

As enacted by the Bush administration, however, the program required agencies to admit to a history of discrimination before qualifying, while the number of industries in which women would be eligible for assistance was severely limited.

The company is working now to gain approval for the pilot program with hopes of eventually expanding the number of taxis involved to the thousands.

Bessant represents the company on a number of important topics, including diversity and inclusion, serving as an executive sponsor for the company's Lesbian, Gay, Bisexual and Transgender Pride executive board and the LGBT Ally program and executive management team sponsor of the company's disability advocacy initiatives.

Some universities are hailing possible new flexibilities, but Dr Yovich says one issue for Murdoch concerns previous block grants now becoming allocations for specific programs, some calculated on the number of students in each.

At last week's Goldman Sachs 10,000 Small Businesses program graduation at LaGuardia Community College in Long Island City, N.Y., and again this week at the White House's United State of Women Summit, Buffett offered his number - one tip for business success.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

For example, a modest payroll program might take hours instead of minutes to complete its number and file processing.

In its early years, a number of her students in the program were teenagers who had come to the country, unauthorized, at a young age and finished high school, but then could not obtain citizenship or receive any state or federal funds for college.